CONSENSUS B Tat-9 extends the minimal domain to incorporate additional basic residues that enhance binding affinity. The sequence adopts conformations suited for nucleic-acid and membrane interactions. Its compact structure supports fine mapping of Tat-derived motifs. Researchers employ it in structural modeling and ligand-interface analysis.
CAT No: H09241
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More